Life Science Big News Roundup: Lexaria Receives Cannabis R&D License; Harvest One Phase II Clinical Trials on Satipharm CBD GelPell® Published in Peer-Reviewed Medical Journal Life Science Investing
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock Pharmaceutical Investing
Harvest One Announces Completion of Phase I of the Shoppers Drug Mart & TruTrace Technologies Pilot Program for Validation of Medical Cannabis Cannabis Investing News
